Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer.
Smoking is associated with both acute myeloid leukemia (AML) and lung cancer. We therefore searched our database for concomitant presentation of AML and lung cancer. Among 775 AML cases and 5225 lung cancer cases presenting to Roswell Park Cancer Institute between the years January 1992 and May 2008 we found 12 (1.5% of AML cases; 0.23% of lung cancer cases) cases (seven metachronous and five synchronous) with AML and lung cancer. All but one patient were smokers. There were no unique characteristic of either AML or lung cancer in these patients. Nine patients succumbed to AML, one died from an unrelated cause while undergoing treatment for AML, one died of lung cancer and one patient is alive after allogeneic transplantation for AML. In summary, this study supports the need for effective smoking cessation programs.
Varadarajan
Ramya
R
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Ford
LaurieAnn
L
Sait
Sheila N J
SN
Block
AnneMarie W
AW
Barcos
Maurice
M
Wallace
Paul K
PK
Ramnath
Nithya
N
Wang
Eunice S
ES
Wetzler
Meir
M
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012907:Smoking / Q000009:adverse effects*